LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for Cerevel Therapeutics and Millions of Other Companies

Sign up for full access to Cerevel Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Deep Neuroscience Focus Cerevel Therapeutics specializes in developing therapies for CNS disorders, offering potential collaborations for companies focusing on mental health solutions.

Recent Acquisition by AbbVie Following the acquisition by AbbVie for $8.7 billion, sales professionals can explore synergies and cross-selling opportunities within the expanded network.

Strong Financial Health With annual revenue between $50-100 million and funding of $450 million, Cerevel offers stable partnerships to companies seeking financially robust collaborations.

Key Personnel Transition Track any changes in key personnel post-acquisition to target decision-makers effectively and align sales strategies accordingly.

Competitive Landscape Analysis Analyzing similar companies like AbbVie, Pfizer, and others can provide insights into potential competitive positioning strategies for sales differentiation and market penetration.

Similar companies to Cerevel Therapeutics

✕

Access Insights for Cerevel Therapeutics and Millions of Other Companies

Sign up for full access to Cerevel Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Cerevel Therapeutics Tech Stack

Cerevel Therapeutics uses 8 technology products and services including Oracle, React, PWA, and more. Explore Cerevel Therapeutics's tech stack below.

  • Oracle
    Enterprise
  • React
    Javascript Frameworks
  • PWA
    Miscellaneous
  • Amazon Web Services
    Platform As A Service
  • WP Engine
    Platform As A Service
  • Smartsheet
    Project Management
  • FedEx
    Transportation And Fleet Management
  • Django
    Web Frameworks

Media & News

Cerevel Therapeutics's Email Address Formats

Cerevel Therapeutics uses at least 1 format(s):
Cerevel Therapeutics Email FormatsExamplePercentage
First.Last@cerevel.comJohn.Doe@cerevel.com
98%
First.L@cerevel.comJohn.D@cerevel.com
2%

Frequently Asked Questions

Where is Cerevel Therapeutics's headquarters located?

Minus sign iconPlus sign iconCerevel Therapeutics's main headquarters is located at 222 Jacobs Street, Suite 200 Suite 200 Cambridge, Massachusetts 02141 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Cerevel Therapeutics's stock symbol?

Minus sign iconPlus sign iconCerevel Therapeutics is a publicly traded company; the company's stock symbol is CERE.

What is Cerevel Therapeutics's official website and social media links?

Minus sign iconPlus sign iconCerevel Therapeutics's official website is cerevel.com and has social profiles on LinkedIn.

How much revenue does Cerevel Therapeutics generate?

Minus sign iconPlus sign icon As of July 2024, Cerevel Therapeutics's annual revenue reached $75M.

What is Cerevel Therapeutics's NAICS code?

Minus sign iconPlus sign iconCerevel Therapeutics's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Cerevel Therapeutics have currently?

Minus sign iconPlus sign iconAs of July 2024, Cerevel Therapeutics has approximately 368 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: T. C.Chief Medical Officer: R. S.Chief Information Officer: D. B.. Explore Cerevel Therapeutics's employee directory with LeadIQ.

What industry does Cerevel Therapeutics belong to?

Minus sign iconPlus sign iconCerevel Therapeutics operates in the Pharmaceutical Manufacturing industry.

What technology does Cerevel Therapeutics use?

Minus sign iconPlus sign iconCerevel Therapeutics's tech stack includes OracleReactPWAAmazon Web ServicesWP EngineSmartsheetFedExDjango.

What is Cerevel Therapeutics's email format?

Minus sign iconPlus sign iconCerevel Therapeutics's email format typically follows the pattern of . Find more Cerevel Therapeutics email formats with LeadIQ.

How much funding has Cerevel Therapeutics raised to date?

Minus sign iconPlus sign icon As of July 2024, Cerevel Therapeutics has raised $450M in funding. The last funding round occurred on Oct 11, 2023 for $450M.

When was Cerevel Therapeutics founded?

Minus sign iconPlus sign iconCerevel Therapeutics was founded in 2018.
Cerevel Therapeutics

Cerevel Therapeutics

Pharmaceutical ManufacturingMassachusetts, United States201-500 Employees

Cerevel Therapeutics is a biopharmaceutical company focused on developing new therapies to treat disorders of the central nervous system (CNS). The company has a portfolio of experimental neuroscience therapies, which include three clinical-stage compounds and several pre-clinical compounds designed to target a broad range of CNS disorders, including Parkinson’s, Alzheimer’s, epilepsy, schizophrenia and addiction. Headquartered in the Greater Boston area, Cerevel was formed in 2018 through a partnership between Bain Capital and Pfizer.

✕

Access Insights for Cerevel Therapeutics and Millions of Other Companies

Sign up for full access to Cerevel Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
222 Jacobs Street, Suite 200 Suite 200 Cambridge, Massachusetts 02141 US
Website
cerevel.com
Stock Symbol
CERE
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2018
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $450M

    Cerevel Therapeutics has raised a total of $450M of funding over 6 rounds. Their latest funding round was raised on Oct 11, 2023 in the amount of $450M.

  • $50M$100M

    Cerevel Therapeutics's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $450M

    Cerevel Therapeutics has raised a total of $450M of funding over 6 rounds. Their latest funding round was raised on Oct 11, 2023 in the amount of $450M.

  • $50M$100M

    Cerevel Therapeutics's revenue is in the range of $50M$100M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for Cerevel Therapeutics and Millions of Other Companies

Sign up for full access to Cerevel Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.